ReviewPharmaceuticals (Basel, Switzerland)2010

EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment.

Olivier Guérin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.